During the past decade, Ahmed Mohamed Hasanin conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ahmed Mohamed Hasanin" are "Anesthesia" (2 trials), "Cesarean Section Complications" (2 trials), "Septic Shock" (2 trials), "Spinal Anesthetic Toxicity" (2 trials) and "Fasting" (1 trials). Many other conditions were trialed in "Ahmed Mohamed Hasanin" in a lesser frequency.

Most popular intervention types in "Ahmed Mohamed Hasanin" are "Drug" (4 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Norepinephrine 10 mcg" (2 trials), "Norepinephrine 6 mcg" (2 trials), "Norepinephrine infusion" (2 trials), "Bupivacaine Hydrochloride" (1 trials) and "Bupivacaine hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ahmed Mohamed Hasanin" are 5 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Ahmed Mohamed Hasanin". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ahmed Mohamed Hasanin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ahmed Mohamed Hasanin, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".